The endocannabinoid system: body weight and metabolic regulation (Q36701773)

15 August 2017

1 reference

title

The endocannabinoid system: body weight and metabolic regulation (English)

1 reference

15 August 2017

main subject

endocannabinoid system

0 references

1

Stefan Engeli

1 reference

15 August 2017

2

Jens Jordan

1 reference

15 August 2017

language of work or name

1 reference

1 January 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

8 Suppl 4

1 reference

15 August 2017

page(s)

S24-35

1 reference

Overweight and obesity as determinants of cardiovascular risk: the Framingham experience.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Obesity and cardiovascular physiology: impact of some pharmacological agents

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Pharmacological therapies for obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Antihypertensive, cardiovascular, and pleiotropic effects of angiotensin-receptor blockers

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Therapeutic roles of peroxisome proliferator-activated receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Molecular cloning of a human cannabinoid receptor which is also expressed in testis

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Molecular characterization of a peripheral receptor for cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Appetite suppression and weight loss after the cannabinoid antagonist SR 141716.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

The endocannabinoid system and its therapeutic exploitation

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Molecular characterization of a phospholipase D generating anandamide and its congeners

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Activation of the peripheral endocannabinoid system in human obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Leptin-regulated endocannabinoids are involved in maintaining food intake

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Blood pressure regulation by endocannabinoids and their receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Cannabinoid-based drugs as anti-inflammatory therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

The molecular logic of endocannabinoid signalling

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Up-regulation of the endocannabinoid system in the uterus of leptin knockout (ob/ob) mice and implications for fertility

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

The endogenous cannabinoid system protects against colonic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Antifibrogenic role of the cannabinoid receptor CB2 in the liver

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Neurobiology Cannabinoids act backwards

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Observational analysis of feeding induced by Delta9-THC and anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

The cannabinoid CB1 receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenic cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

The cannabinoid system: a role in both the homeostatic and hedonic control of eating?

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Tetrahydrocannabinol and endocannabinoids in feeding and appetite

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Cocaine- and amphetamine-related transcript is involved in the orexigenic effect of endogenous anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

The emerging role of the endocannabinoid system in endocrine regulation and energy balance

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Food for thought: endocannabinoid modulation of lipogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

SREBP transcription factors: master regulators of lipid homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Cannabinoid receptor signaling directly inhibits thermogenesis and alters expression of adiponectin and visfatin

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Towards a molecular understanding of adaptive thermogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Anandamide induced PPARgamma transcriptional activation and 3T3-L1 preadipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Adiponectin: action, regulation and association to insulin sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

CREB activation induces adipogenesis in 3T3-L1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Down-regulation of cannabinoid-1 (CB-1) receptors in specific extrahypothalamic regions of rats with dietary obesity: a role for endogenous cannabinoids in driving appetite for palatable food?

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH).

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2806%2980041-4

7 January 2021

10.1016/S1098-3597(06)80041-4

Identifiers

DOI

1 reference

15 August 2017

1 reference